2025-07-14 - Analysis Report
Okay, here's an analysis of Eli Lilly and Co (LLY) based on the provided data, formatted as requested:

## Eli Lilly and Co (LLY) Analysis

**Eli Lilly and Co is a global pharmaceutical company that discovers, develops, manufactures, and markets pharmaceutical products.**

### 1. Performance vs. S&P 500 (VOO)

*   **Cumulative Return (LLY):** 256.89%
*   **Cumulative Return (VOO):** 95.46%
*   **Absolute Spread:** 161.4
*   **Relative Spread:** 55.7 (Indicates LLY's outperformance is in the upper half of its historical range relative to VOO)

**Analysis:** LLY has significantly outperformed the S&P 500 (VOO) over the analyzed period. The relative spread suggests that this outperformance, while substantial, is not unprecedented in LLY's recent history.

### 2. Alpha, Beta Analysis

| Year       | CAGR    | MDD    | Alpha   | Beta | Cap(B) |
|------------|---------|--------|---------|------|--------|
| 2015-2017  | 10.0%   | 56.3%  | -19.0%  | 0.0  | 75.8   |
| 2016-2018  | 39.0%   | 58.6%  | 21.0%   | -0.1 | 103.9  |
| 2017-2019  | 50.0%   | 58.6%  | 20.0%   | 0.3  | 118.0  |
| 2018-2020  | 52.0%   | 58.6%  | 33.0%   | 0.1  | 151.6  |
| 2019-2021  | 106.0%  | 60.6%  | 57.0%   | 0.2  | 248.0  |
| 2020-2022  | 98.0%   | 64.8%  | 96.0%   | 0.2  | 328.4  |
| 2021-2023  | 133.0%  | 64.8%  | 115.0%  | 0.3  | 523.3  |
| 2022-2024  | 150.0%  | 72.2%  | 124.0%  | 0.2  | 693.1  |
| 2023-2025  | 110.0%  | 76.8%  | 62.0%   | 0.2  | 711.9  |

**Analysis:**

*   **CAGR:**  Shows strong compounded annual growth, especially in recent periods.
*   **MDD:** High Maximum Drawdown values suggests the stock is prone to significant declines.
*   **Alpha:** Consistently positive and increasing alpha suggests LLY is generating excess returns relative to its benchmark(S&P 500).
*   **Beta:**  Generally low (around 0.2 or less), indicating lower sensitivity to market movements (S&P 500).
*   **Cap(B):**  Market capitalization has grown significantly, reflecting the company's growth.

### 3. Recent Price Movement

*   **Current Price:** 793.01
*   **Last-market:** Price: 793.09, Previous Close: 792.89, Change: 0.03
*   **5-Day Moving Average:** 784.22
*   **20-Day Moving Average:** 786.42
*   **60-Day Moving Average:** 781.26

**Analysis:**  The current price is slightly above all three moving averages, suggesting a short-term upward trend. The very small change from the previous close suggests minimal price movement in the last market session. The stock is trading slightly higher, but not indicating a strong momentum shift based on this data alone.

### 4. Indicators

*   **Market Risk Indicator (MRI):** 0.3294 (Low Risk)
*   **RSI:** 66.03 (Approaching overbought territory but not yet there)
*   **PPO:** 0.0468 (Positive, indicating bullish momentum)
*   **Hybrid Signal:** cash_0%_Buy 90% of cash (1 shares - Safe - MRI:0.33)
*   **20-Day Relative Spread Change:** 1.8 (Positive, short-term increase in relative outperformance)
*   **Expected Return (%):** 130.6 (Significant long-term expected outperformance vs. S&P 500)

**Analysis:** The MRI suggests a low-risk environment for the stock. The RSI indicates the stock is nearing overbought territory, potentially signaling a pullback.  A positive PPO supports bullish momentum. The Hybrid Signal suggests a buying opportunity with most cash deployed, indicating confidence in the stock. The positive change in relative spread and high expected return are strongly positive signals.

### 5. Recent News & Significant Events

*   **[2025-07-12]:**  Major business developments, regulatory changes, or market events.
*   **[2025-07-13]:**  Analyst discussions on performance and outlook.
*   **[2025-07-14]:**  Stock volatility influenced by news, earnings, or executive actions.
*   **[2025-07-10]:**  Market experts highlighting risks and opportunities.

**Analysis:** Recent news suggests potential volatility and significant developments surrounding LLY. It's important to investigate the specific details of these events to understand their potential impact.

### 6. Recent Earnings Analysis

| Date       | EPS  | Revenue      |
|------------|------|--------------|
| 2025-05-01 | 3.07 | 12.73 B$     |
| 2024-10-30 | 1.08 | 11.44 B$     |
| 2024-08-08 | 3.29 | 11.30 B$     |
| 2024-04-30 | 2.49 | 8.77 B$     |
| 2025-05-01 | 2.49 | 8.77 B$     |

**Analysis:** The earnings data shows fluctuating EPS and revenue. Revenue has generally been increasing, suggesting growth. Note that 2025-05-01 is listed twice with different EPS/Revenue. The general trend is upward revenue

### 7. Financial Information

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
|--------------|-----------|---------------|
| 2025-03-31   | $12.73B  | 82.53%        |
| 2024-12-31   | $13.53B  | 82.24%        |
| 2024-09-30   | $11.44B  | 81.02%        |
| 2024-06-30   | $11.30B  | 80.80%        |
| 2024-03-31   | $8.77B   | 80.91%        |

**Capital and Profitability:**

| Quarter      | Equity    | ROE    |
|--------------|-----------|--------|
| 2025-03-31   | $15.76B  | 17.50% |
| 2024-12-31   | $14.19B  | 31.07% |
| 2024-09-30   | $14.24B  | 6.81%  |
| 2024-06-30   | $13.56B  | 21.88% |
| 2024-03-31   | $12.81B  | 17.51% |

**Analysis:**

*   **Revenue and Profitability:**  Shows strong revenue growth, and the high profit margins are very impressive and consistent, indicating strong pricing power and efficient operations.
*   **Capital and Profitability:**  Equity has been growing, and ROE (Return on Equity) fluctuates, but is generally strong, showing that LLY is effectively using shareholder investments to generate profits.

### 8. Overall Summary

Eli Lilly and Co (LLY) demonstrates a strong financial profile with significant outperformance compared to the S&P 500. Recent earnings and financial data indicate robust revenue growth and high profitability. The low Market Risk Indicator and positive short-term momentum suggest a potentially favorable investment environment. However, the approaching overbought RSI and recent news events indicating volatility warrant careful consideration. The high expected return suggests strong long-term potential. Overall, LLY appears to be a strong performer with positive indicators, but continued monitoring of news and market conditions is crucial.
